Akira Ikari

4.4k total citations
190 papers, 3.6k citations indexed

About

Akira Ikari is a scholar working on Molecular Biology, Neurology and Cell Biology. According to data from OpenAlex, Akira Ikari has authored 190 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 56 papers in Neurology and 40 papers in Cell Biology. Recurrent topics in Akira Ikari's work include Barrier Structure and Function Studies (55 papers), Aldose Reductase and Taurine (31 papers) and Neurological Disease Mechanisms and Treatments (25 papers). Akira Ikari is often cited by papers focused on Barrier Structure and Function Studies (55 papers), Aldose Reductase and Taurine (31 papers) and Neurological Disease Mechanisms and Treatments (25 papers). Akira Ikari collaborates with scholars based in Japan, Australia and United States. Akira Ikari's co-authors include Satoshi Endo, Toshiyuki Matsunaga, Junko Sugatani, Yasuhiro Yamazaki, Masao Miwa, Hitoshi Harada, Kuniaki Takagi, Hideki Sakai, Suketami Tominaga and Yasunobu Suketa and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Hepatology.

In The Last Decade

Akira Ikari

185 papers receiving 3.6k citations

Peers

Akira Ikari
Akira Ikari
Citations per year, relative to Akira Ikari Akira Ikari (= 1×) peers Satoshi Endo

Countries citing papers authored by Akira Ikari

Since Specialization
Citations

This map shows the geographic impact of Akira Ikari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akira Ikari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akira Ikari more than expected).

Fields of papers citing papers by Akira Ikari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akira Ikari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akira Ikari. The network helps show where Akira Ikari may publish in the future.

Co-authorship network of co-authors of Akira Ikari

This figure shows the co-authorship network connecting the top 25 collaborators of Akira Ikari. A scholar is included among the top collaborators of Akira Ikari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akira Ikari. Akira Ikari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Takaya, Daisuke, Kaori Fukuzawa, Yuta Yoshino, et al.. (2024). Docosahexaenoic acid enhances the treatment efficacy for castration-resistant prostate cancer by inhibiting autophagy through Atg4B inhibition. Archives of Biochemistry and Biophysics. 760. 110135–110135. 6 indexed citations
3.
Hara, Hiroaki, et al.. (2024). Possible involvement of up-regulated salt-dependent glucose transporter-5 (SGLT5) in high-fructose diet-induced hypertension. Hypertension Research. 48(3). 1068–1079. 3 indexed citations
4.
Yoshino, Yuta, et al.. (2023). Activation of the TGF-β1/EMT signaling pathway by claudin-1 overexpression reduces doxorubicin sensitivity in small cell lung cancer SBC-3 cells. Archives of Biochemistry and Biophysics. 751. 109824–109824. 5 indexed citations
5.
Yoshino, Yuta, et al.. (2023). Inhibition of aldo-keto reductase 1C3 overcomes gemcitabine/cisplatin resistance in bladder cancer. Chemico-Biological Interactions. 388. 110840–110840. 6 indexed citations
6.
Ito, Ayaka, et al.. (2021). Elevation of Chemosensitivity of Lung Adenocarcinoma A549 Spheroid Cells by Claudin-2 Knockdown through Activation of Glucose Transport and Inhibition of Nrf2 Signal. International Journal of Molecular Sciences. 22(12). 6582–6582. 13 indexed citations
8.
Endo, Satoshi, et al.. (2021). Loxoprofen enhances intestinal barrier function via generation of its active metabolite by carbonyl reductase 1 in differentiated Caco-2 cells. Chemico-Biological Interactions. 348. 109634–109634. 5 indexed citations
9.
Morikawa, Yoshifumi, Koichi Suenami, Kiyohito Sato, et al.. (2020). 4′-Fluoropyrrolidinononanophenone elicits neuronal cell apoptosis through elevating production of reactive oxygen and nitrogen species. Forensic Toxicology. 39(1). 123–133. 8 indexed citations
10.
Ishikawa, Yoshinobu, Takehiro Shinoda, Mikako Shirouzu, et al.. (2020). Claudin-2 binding peptides, VPDSM and DSMKF, down-regulate claudin-2 expression and anticancer resistance in human lung adenocarcinoma A549 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(4). 118642–118642. 13 indexed citations
11.
Fujii, Takuto, Takahiro Shimizu, Shota Yamamoto, et al.. (2018). Crosstalk between Na+,K+-ATPase and a volume-regulated anion channel in membrane microdomains of human cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(11). 3792–3804. 39 indexed citations
12.
Yamaguchi, Masahiko, Masakazu Matsui, Yasuhiro Yamazaki, et al.. (2015). A platelet-activating factor (PAF) receptor deficiency exacerbates diet-induced obesity but PAF/PAF receptor signaling does not contribute to the development of obesity-induced chronic inflammation. Biochemical Pharmacology. 93(4). 482–495. 13 indexed citations
13.
Arai, Yuki, Satoshi Endo, Naohito Abe, et al.. (2014). Structure–activity relationship of flavonoids as potent inhibitors of carbonyl reductase 1 (CBR1). Fitoterapia. 101. 51–56. 30 indexed citations
14.
Ikari, Akira, Yasuhiro Yamazaki, Hideki Sakai, et al.. (2013). Hyperosmolarity-induced up-regulation of claudin-4 mediated by NADPH oxidase-dependent H2O2 production and Sp1/c-Jun cooperation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(12). 2617–2627. 21 indexed citations
15.
Sugatani, Junko, Takahiro Uchida, Masahiko Yamaguchi, et al.. (2012). Regulation of Pregnane X Receptor (PXR) Function and UGT1A1 Gene Expression by Posttranslational Modification of PXR Protein. Drug Metabolism and Disposition. 40(10). 2031–2040. 43 indexed citations
16.
Ikari, Akira, et al.. (2012). Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(6). 1110–1118. 82 indexed citations
17.
Tsukimoto, Mitsutoshi, et al.. (2006). P2X7 Receptor-Dependent Cell Death Is Modulated during Murine T Cell Maturation and Mediated by Dual Signaling Pathways. The Journal of Immunology. 177(5). 2842–2850. 73 indexed citations
18.
Ikari, Akira, Yoshiaki Nagatani, Mitsutoshi Tsukimoto, et al.. (2005). Sodium-dependent glucose transporter reduces peroxynitrite and cell injury caused by cisplatin in renal tubular epithelial cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1717(2). 109–117. 38 indexed citations
19.
Ikari, Akira, Kumiko Nakajima, Yasunobu Suketa, Hitoshi Harada, & Kuniaki Takagi. (2003). Arachidonic acid-activated Na+-dependent Mg2+ efflux in rat renal epithelial cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1618(1). 1–7. 9 indexed citations
20.
Tabuchi, Yoshiaki, et al.. (2002). Stable Expression of Gastric Proton Pump Activity at the Cell Surface. The Journal of Biochemistry. 131(6). 923–932. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026